Center for Global Health and Development, Boston University, Boston, MA, USA.
J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):322-328. doi: 10.1097/QAI.0b013e31827e8785.
Few studies have compared hospitalizations before and after antiretroviral therapy (ART) initiation in the same patients. We analyzed the cost of hospitalizations among 3906 adult patients in 2 South African hospitals, 30% of whom initiated ART. Hospitalizations were 50% and 40% more frequent and 1.5 and 2.6 times more costly at a CD4 cell count, 100 cells/mm(3) when compared with 200–350 cells/mm(3) in the pre-ART and ART period, respectively. Mean inpatient cost per patient year was USD 117 (95%confidence interval, 85 to 158) for patients on ART and USD 72(95% confidence interval, 56 to 89) for pre-ART patients. Raising ART eligibility thresholds could avoid the high cost of hospitalization before and immediately after ART initiation.
很少有研究在同一患者中比较抗逆转录病毒治疗 (ART) 前后的住院情况。我们分析了南非 2 家医院 3906 名成年患者的住院费用,其中 30%的患者开始接受 ART。与 ART 前和 ART 期间的 200-350 个细胞/立方毫米相比,CD4 细胞计数为 100 个细胞/立方毫米时,住院率分别增加了 50%和 40%,住院费用分别增加了 1.5 倍和 2.6 倍。ART 患者的每位患者每年平均住院费用为 117 美元(95%置信区间,85 至 158),而 ART 前患者为 72 美元(95%置信区间,56 至 89)。提高 ART 资格标准可以避免在开始接受 ART 之前和之后立即住院的高昂费用。